Reports
Reports
Sale
The global cellulite treatment market size attained a value of nearly USD 1.94 billion in 2023. The market is anticipated to grow at a CAGR of 10.9% during the forecast period of 2024-2032 to reach a value of USD 4.91 billion by 2032. The growth of the market can be attributed to the high demand for cosmetic procedures and the presence of advanced healthcare infrastructure.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Cellulite has a dimpled and lumpy appearance on the skin. Because of its texture, cellulite is also known as orange-peel skin. A low-fat diet, cessation of smoking, and an active lifestyle can assist in decreasing cellulite incidence. Various cellulite treatments are also available to help in the removal of cellulite. The cellulite treatment market can be divided on the basis of segments like treatment type, technique, and end-use.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market can be broadly categorised on the basis of its end-use into:
The market can be classified on the basis of its treatment types into energy-based treatment and non-energy-based treatment. Energy-based treatment can be further subdivided into mechanical suction, mechanical suction and thermal, radiofrequency, ultrasound, cryolipolysis, and others.
The EMR report looks into the regional markets for cellulite treatment like North America, LATAM, Europe, the Middle East and Africa, and the Asia Pacific regions.
The major driver of the cellulite treatment market is the growing prevalence of obesity. Approximately half of the world’s population is dissatisfied with their appearance, while three-fourth of the population sought treatment to rectify their appearance. These factors have been driving the market growth over the past five years.
Technological innovations and improvements, along with new product launches are expected to fuel the market demand. Social media promotions and advertisements are projected to influence a large customer base, which will accelerate the industry growth.
The major drivers for the industry in North America are the high awareness about the latest medical developments among prospective consumers and a well-developed health care infrastructure. The Asia Pacific market is anticipated to grow significantly as market players working in the aesthetic sector in countries like India and China are increasing their penetration. The high cost of the treatment restricts the growth of the consumer base, which can be a major limitation for this industry growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The report presents a detailed analysis of the following key players in the global cellulite treatment market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s five forces.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Treatment Type |
|
Breakup by Procedure Type |
|
Breakup by Cellulite Type |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Cellulite Diseases Overview
3.1 Guidelines and Stages
3.2 Pathophysiology
3.3 Screening and Diagnosis
3.4 Treatment Pathway
4 Patient Profile
4.1 Patient Profile Overview
4.2 Patient Psychology and Emotional Impact Factors
4.3 Risk Assessment and Treatment Success Rate
4.4 Global Contraceptive Drugs Product Landscape
5 Cellulite Epidemiology Analysis
5.1 Epidemiology Overview (2016-2031)
5.2 North America Cellulite Epidemiology (2016-2031)
5.3 Europe Cellulite Epidemiology (2016-2031)
5.4 Asia-Pacific Cellulite Epidemiology (2016-2031)
5.5 Latin America Cellulite Epidemiology (2016-2031)
5.6 Middle East & Africa Cellulite Epidemiology (2016-2031)
6 Global Cellulite Treatment Market Overview
6.1 Global Cellulite Treatment Market Historical Value (2017-2023)
6.2 Global Cellulite Treatment Market Forecast Value (2024-2032)
7 Global Cellulite Treatment Market Landscape
7.1 Cellulite Treatment: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Cellulite Treatment: Product Landscape
7.2.1 Analysis by Treatment Type
7.2.2 Analysis by Procedure Type
7.2.3 Analysis by Cellulite Type
7.2.4 Analysis by End User
8 Cellulite Treatment Challenges and Unmet Needs
8.1 Treatment Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Treatment
10 Global Cellulite Treatment Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Global Cellulite Treatment Market Segmentation
11.1 Global Cellulite Treatment Market by Treatment Type
11.1.1 Market Overview
11.1.2 Energy-Based Treatment
11.1.2.1 Mechanical Suction and Thermal
11.1.2.2 Radiofrequency
11.1.2.3 Ultrasound
11.1.2.4 Cry lipolysis
11.1.2.5 Mechanical Suction
11.1.2.6 Others
11.1.3 Non-Energy Based Treatment
11.2 Global Cellulite Treatment Market by Procedure Type
11.2.1 Market Overview
11.2.2 Non-invasive
11.2.3 Minimally Invasive
11.2.4 Topical
11.3 Global Cellulite Treatment Market by Cellulite Type
11.3.1 Market Overview
11.3.2 Soft Cellulite
11.3.3 Hard Cellulite
11.3.4 Edematous Cellulite
11.4 Global Cellulite Treatment Market by End User
11.4.1 Market Overview
11.4.2 Hospitals
11.4.3 Specialty Clinics
11.4.4 Ambulatory Surgical Centers
11.4.5 Others
11.5 Global Cellulite Treatment Market by Region
11.5.1 Market Overview
11.5.2 North America
11.5.3 Europe
11.5.4 Asia Pacific
11.5.5 Latin America
11.5.6 Middle East and Africa
12 North America Cellulite Treatment Market
12.1 Market Share by Country
12.2 United States of America
12.3 Canada
13 Europe Cellulite Treatment Market
13.1 Market Share by Country
13.2 United Kingdom
13.3 Germany
13.4 France
13.5 Italy
13.6 Others
14 Asia Pacific Cellulite Treatment Market
14.1 Market Share by Country
14.2 China
14.3 Japan
14.4 India
14.5 ASEAN
14.6 Australia
14.7 Others
15 Latin America Cellulite Treatment Market
15.1 Market Share by Country
15.2 Brazil
15.3 Argentina
15.4 Mexico
15.5 Others
16 Middle East and Africa Cellulite Treatment Market
16.1 Market Share by Country
16.2 Saudi Arabia
16.3 United Arab Emirates
16.4 Nigeria
16.5 South Africa
16.6 Others
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Patent Analysis
18.1 Analysis by Type of Patent
18.2 Analysis by Publication year
18.3 Analysis by Issuing Authority
18.4 Analysis by Patent Age
18.5 Analysis by CPC Analysis
18.6 Analysis by Patent Valuation
18.7 Analysis by Key Players
19 Grants Analysis
19.1 Analysis by year
19.2 Analysis by Amount Awarded
19.3 Analysis by Issuing Authority
19.4 Analysis by Grant Application
19.5 Analysis by Funding Institute
19.6 Analysis by NIH Departments
19.7 Analysis by Recipient Organization
20 Clinical Trials Analysis
20.1 Analysis by Trial Registration Year
20.2 Analysis by Trial Status
20.3 Analysis by Trial Phase
20.4 Analysis by Therapeutic Area
20.5 Analysis by Geography
21 Funding and Investment Analysis
21.1 Analysis by Funding Instances
21.2 Analysis by Type of Funding
21.3 Analysis by Funding Amount
21.4 Analysis by Leading Players
21.5 Analysis by Leading Investors
21.6 Analysis by Geography
22 Partnership and Collaborations Analysis
22.1 Analysis by Partnership Instances
22.2 Analysis by Type of Partnership
22.3 Analysis by Leading Players
22.4 Analysis by Geography
23 Supplier Landscape
23.1 Cutera
23.1.1 Financial Analysis
23.1.2 Product Portfolio
23.1.3 Demographic Reach and Achievements
23.1.4 Mergers and Acquisitions
23.1.5 Certifications
23.2 Nestle
23.2.1 Financial Analysis
23.2.2 Product Portfolio
23.2.3 Demographic Reach and Achievements
23.2.4 Mergers and Acquisitions
23.2.5 Certifications
23.3 Merz Pharmaceuticals, LLC
23.3.1 Financial Analysis
23.3.2 Product Portfolio
23.3.3 Demographic Reach and Achievements
23.3.4 Mergers and Acquisitions
23.3.5 Certifications
23.4 Inceler Medikal Co Ltd.
23.4.1 Financial Analysis
23.4.2 Product Portfolio
23.4.3 Demographic Reach and Achievements
23.4.4 Mergers and Acquisitions
23.4.5 Certifications
23.5 Shanghai Fosun Pharmaceutical Group Co. Ltd.
23.5.1 Financial Analysis
23.5.2 Product Portfolio
23.5.3 Demographic Reach and Achievements
23.5.4 Mergers and Acquisitions
23.5.5 Certifications
23.6 Hologic Inc.
23.6.1 Financial Analysis
23.6.2 Product Portfolio
23.6.3 Demographic Reach and Achievements
23.6.4 Mergers and Acquisitions
23.6.5 Certifications
23.7 Candela Corporation
23.7.1 Financial Analysis
23.7.2 Product Portfolio
23.7.3 Demographic Reach and Achievements
23.7.4 Mergers and Acquisitions
23.7.5 Certifications
23.8 Mentor Worldwide LLC
23.8.1 Financial Analysis
23.8.2 Product Portfolio
23.8.3 Demographic Reach and Achievements
23.8.4 Mergers and Acquisitions
23.8.5 Certifications
23.9 Zimmer Aesthetics
23.9.1 Financial Analysis
23.9.2 Product Portfolio
23.9.3 Demographic Reach and Achievements
23.9.4 Mergers and Acquisitions
23.9.5 Certifications
23.10 Tanceuticals
23.10.1 Financial Analysis
23.10.2 Product Portfolio
23.10.3 Demographic Reach and Achievements
23.10.4 Mergers and Acquisitions
23.10.5 Certifications
23.11 Nubway Co. Ltd.
23.11.1 Financial Analysis
23.11.2 Product Portfolio
23.11.3 Demographic Reach and Achievements
23.11.4 Mergers and Acquisitions
23.11.5 Certifications
23.12 Allergan
23.12.1 Financial Analysis
23.12.2 Product Portfolio
23.12.3 Demographic Reach and Achievements
23.12.4 Mergers and Acquisitions
23.12.5 Certifications
24 Cellulite Treatment Market- Distribution Model (Additional Insight)
24.1 Overview
24.2 Potential Distributors
24.3 Key Parameters for Distribution Partner Assessment
25 Key Opinion Leaders (KOL) Insights (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
26.1 Very Small Companies
26.2 Small Companies
26.3 Mid-Sized Companies
26.4 Large Companies
26.5 Very Large Companies
27 Payment Methods (Additional Insight)
27.1 Government Funded
27.2 Private Insurance
27.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
The global cellulite treatment market reached a value of USD 1.94 million in 2023.
In the forecast period 0f 2024-2032, the industry is projected to grow at a CAGR of 10.9%.
The major factor which is expected to aid the industry growth includes the growing prevalence of obesity.
Technological innovations and improvements in the industry are expected to define the market growth in the coming years.
North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa are the major regions in the market.
The leading treatment types of cellulite treatment in the market are energy-based and non-energy based treatment.
Non-invasive and minimally invasive, among others, are the significant techniques of the product in the industry.
The major end use sectors in the market are hospitals, dermatology clinics and cosmetic surgery centres.
The major players in the market are Cynosure, Inc., Cutera, Inc., Nestlé S.A., Merz, Inc, Mentor Worldwide LLC, Fosun Pharmaceutical Co., Ltd., Allergan plc, and Syneron Medical Ltd., among others.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.